News | January 06, 2026
PathoCare Holdings valued at $1.75 billion following major third-party tender offer
The company previously completed a $150 million venture investment, acquisition, and recapitalization
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
She will lead efforts to deepen regional market presence, foster innovation, and support scientific advancement across South Asia
She has held senior positions at Coca-Cola in China and PepsiCo in India
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
Subscribe To Our Newsletter & Stay Updated
